Dr. P. Banerji'S Homoeopathic Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-06-2024
- Paid Up Capital ₹ 0.10 M
as on 18-06-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1.49%
(FY 2023)
- Profit 1.32%
(FY 2023)
- Ebitda -55.80%
(FY 2023)
- Net Worth 36.72%
(FY 2023)
- Total Assets 13.93%
(FY 2023)
About Dr. P. Banerji'S Homoeopathic Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Namita Dutta, Sukanya Dutta, and Paramesh Banerji serve as directors at the Company.
- CIN/LLPIN
U85193WB2013PTC192570
- Company No.
192570
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr. P. Banerji'S Homoeopathic Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Namita Dutta  | Additional Director | 15-Apr-2016 | Current |
| Sukanya Dutta | Director | 23-Apr-2013 | Current |
| Paramesh Banerji | Director | 23-Apr-2013 | Current |
Financial Performance of Dr. P. Banerji'S Homoeopathic Healthcare.
Dr. P. Banerji'S Homoeopathic Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.49% increase. The company also saw a slight improvement in profitability, with a 1.32% increase in profit. The company's net worth Soared by an impressive increase of 36.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. P. Banerji'S Homoeopathic Healthcare?
In 2023, Dr. P. Banerji'S Homoeopathic Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pbls India Private LimitedActive 3 years 8 monthsSukanya Dutta and Paramesh Banerji are mutual person
- P B M Cybernetics Pvt LtdActive 34 years 2 months
Sukanya Dutta and Paramesh Banerji are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. P. Banerji'S Homoeopathic Healthcare?
Unlock and access historical data on people associated with Dr. P. Banerji'S Homoeopathic Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. P. Banerji'S Homoeopathic Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. P. Banerji'S Homoeopathic Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
